Mary Chapman, features writer —

Myeloma Action Month (MAM) is observed each March to call attention to multiple myeloma and the people affected by it, and this year’s event will focus on bringing hope to patients and caregivers through action. The international campaign is designed to improve awareness of myeloma among policymakers, researchers,…

Blood Cancer Awareness Month, observed globally every September, seeks to raise awareness of all blood malignancies — there’s one case of blood cancer diagnosed every three minutes in the U.S. alone — with advocacy and research groups launching new campaigns each year. For its part, the International Myeloma…

Janssen and radio host and comedian D.L. Hughley are partnering to call attention to multiple myeloma in Black communities, with a goal of driving better patient outcomes. The national campaign, “That’s My Word,” will provide information and resources specifically for African Americans — who are at a…

For this Myeloma Action Month (MAM), observed each March to call attention to multiple myeloma and those affected by the blood disorder, the International Myeloma Foundation (IMF) is focusing on telling the myeloma community’s stories. The global event is aimed at heightening awareness of myeloma, which accounts…

Following a three-year hiatus due to the COVID-19 pandemic, the Patient and Family Seminar hosted by the International Myeloma Foundation (IMF) will return to its in-person format for 2023. The free event, which also may be attended virtually, is slated for March 17-18 in Boca Raton, Florida. It’s…

The International Myeloma Foundation’s (IMF) M-Power project, which seeks to improve disease outcomes for African Americans with multiple myeloma, has formed a partnership with yet another U.S. city, this time New York. Myeloma is the most common blood cancer among Black Americans, who have an above-average risk of the…

For this Blood Cancer Awareness Month, observed each September, the International Myeloma Foundation (IMF) is focusing on educating people about multiple myeloma, the second most common type of blood cancer. The month is set aside to heighten awareness about all blood cancers, which are diagnosed every three minutes…

The Paula and Rodger Riney Foundation continues to support the Dana-Farber Cancer Institute in its efforts to advance multiple myeloma research, this time with a $40 million grant. This gift — the largest single award to myeloma research in Dana-Farber’s history — brings the foundation’s donations to the institute…

A new research center at Ohio State University (OSU) aims to speed work into the discovery and development of more effective treatments for those with multiple myeloma. The Riney Family Foundation Myeloma Center for Advanced Research Excellence (Myeloma CARE) is being established through a $10 million gift from the…

A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and parity in care for underserved patient populations. The initiative seeks to extend the reach of clinical studies to underserved populations in the nation’s urban and rural…